Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 569.72M |
| Enterprise Value | 650.28M |
| P/E Ratio | -10.32 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0.25 |
| Price/Book Ratio | 0.96 |
| Enterprise/Revenue | 0.29 |
| Enterprise/EBITDA | -31.4 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.12 |
| Operating Margin | -0.02 |
AD
Management Effectiveness
| Return On Assets | -0.25 |
| Return On Equity | -6.35 |
Income Statement
| Revenue | 509.43M |
| Revenue/Share | 4.13 |
| Gross Profit | 34.75M |
| EBITDA | -14.08M |
| Net Income | -88.47M |
| Diluted EPS | -0.04 |
Balance Sheet
| Total Cash | 65.29M |
| Total Cash/Share | 0.31 |
| Total Debt | 108.79M |
| Total Debt/Equity | 4.85 |
| Current Ratio | 0.8 |
| Book Value Per Share | 0.13 |
Price History
| 52-Week Change | -68.68 |
| 52-Week High | 0.4 |
| 52-Week Low | 0.11 |
| Moving Average 50 Days | 0.21 |
| Moving Average 200 Days | 0.23 |
Statistics
| Average Volume | 1.03M |
| Shares Outstanding | 2.13B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
